CareRx Past Earnings Performance

Past criteria checks 0/6

CareRx has been growing earnings at an average annual rate of 15%, while the Consumer Retailing industry saw earnings growing at 9.2% annually. Revenues have been growing at an average rate of 29% per year.

Key information

15.0%

Earnings growth rate

46.6%

EPS growth rate

Consumer Retailing Industry Growth10.3%
Revenue growth rate29.0%
Return on equity-6.6%
Net Margin-1.5%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Apr 22
Does CareRx (TSE:CRRX) Have A Healthy Balance Sheet?

Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

Mar 17
Market Participants Recognise CareRx Corporation's (TSE:CRRX) Revenues Pushing Shares 28% Higher

CareRx (TSE:CRRX) Takes On Some Risk With Its Use Of Debt

Oct 19
CareRx (TSE:CRRX) Takes On Some Risk With Its Use Of Debt

What You Can Learn From CareRx Corporation's (TSE:CRRX) P/S

Aug 22
What You Can Learn From CareRx Corporation's (TSE:CRRX) P/S

CareRx (TSE:CRRX) Has A Somewhat Strained Balance Sheet

Sep 22
CareRx (TSE:CRRX) Has A Somewhat Strained Balance Sheet

These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively

May 14
These 4 Measures Indicate That CareRx (TSE:CRRX) Is Using Debt Extensively

Here's Why CareRx (TSE:CRRX) Has A Meaningful Debt Burden

Jan 21
Here's Why CareRx (TSE:CRRX) Has A Meaningful Debt Burden

Is CareRx Corporation's (TSE:CRRX) Shareholder Ownership Skewed Towards Insiders?

Mar 15
Is CareRx Corporation's (TSE:CRRX) Shareholder Ownership Skewed Towards Insiders?

Trade Alert: The Chairman Emeritus Of CareRx Corporation (TSE:CRRX), Jack Shevel, Has Just Spent CA$850k Buying 9.4% More Shares

Feb 08
Trade Alert: The Chairman Emeritus Of CareRx Corporation (TSE:CRRX), Jack Shevel, Has Just Spent CA$850k Buying 9.4% More Shares

Reflecting on CareRx's (TSE:CRRX) Share Price Returns Over The Last Three Years

Dec 29
Reflecting on CareRx's (TSE:CRRX) Share Price Returns Over The Last Three Years

Is CareRx (TSE:CRRX) Using Too Much Debt?

Dec 03
Is CareRx (TSE:CRRX) Using Too Much Debt?

Revenue & Expenses Breakdown
Beta

How CareRx makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSX:CRRX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23371-5980
30 Sep 23374-61000
30 Jun 23378-71000
31 Mar 23380-341010
31 Dec 22382-341030
30 Sep 22384-341010
30 Jun 22358-36940
31 Mar 22311-20830
31 Dec 21263-23710
30 Sep 21212-21610
30 Jun 21187-24550
31 Mar 21177-29520
31 Dec 20162-18480
30 Sep 20148-50440
30 Jun 20134-47420
31 Mar 20126-34410
31 Dec 19125-46410
30 Sep 19122-19420
30 Jun 19119-20410
31 Mar 19117-39410
31 Dec 18119-35410
30 Sep 1885-27270
30 Jun 1897-23310
31 Mar 18110-3340
31 Dec 17122-4380
30 Sep 17168-6550
30 Jun 17170-3560
31 Mar 17170-13580
31 Dec 16167-18590
30 Sep 16166-21640
30 Jun 16166-34660
31 Mar 16164-30670
31 Dec 15161-35670
30 Sep 1527-47130
30 Jun 1560-48270
31 Mar 1597-49410
31 Dec 14135-44550
30 Sep 14301-481200
30 Jun 14295-431190
31 Mar 14289-491190
31 Dec 13281-391190
30 Sep 13319-571530
30 Jun 13358-581760

Quality Earnings: CRRX is currently unprofitable.

Growing Profit Margin: CRRX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CRRX is unprofitable, but has reduced losses over the past 5 years at a rate of 15% per year.

Accelerating Growth: Unable to compare CRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CRRX is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (9.2%).


Return on Equity

High ROE: CRRX has a negative Return on Equity (-6.63%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.